• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

ACC 2019: Abbott touts reduced stroke, bleeding and pump-clotting in HeartMate 3 trial

cafead

Administrator
Staff member
  • cafead   Mar 18, 2019 at 12:52: PM
via Abbott (NYSE:ABT) yesterday presented data from a new trial of its HeartMate 3 left ventricular assist device, touting a reduced rate of strokes, pump-related blood clots and bleeding episodes at two years as compared with the previous generation HeartMate II.

article source
 

<